Lumida
/HQY
⌘K
Healthequity Inc

Healthequity Inc

HQY
$96.26USD+1.81%+1.71 today

MARKET CAP

8.0B

P/E (TTM)

39.1x

FWD P/E

DAY RANGE

$94 – $97

52W RANGE

$73
$108

AI Summary

Stalk
Sell NowMedium

HQY suffered a support failure in late August on high volume, confirming medium-term bearish control. Price is extended below declining 9/20/50 EMAs with rejection at resistance and RSI remains in bearish territory without reversal signals. Execution favors immediate sell-side participation while remaining alert to potential oversold relief rallies into broken support and moving averages.

  • Q2 FY27 revenue $350.7M (+8% YoY), net income $65.6M (+10%).
  • HSA accounts at 10.7M (+5% YoY); assets hit $37.9B (+14%).
  • Healthcare costs rising at near double-digit rates may dampen HSA contributions.
Full analysis →

Buying

5

institutions

Selling

9

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY11.28 M1.02 B+745.52 K+15.7%0.02%
AC

Aqr Capital Management LLC

Q2 2026

SELL2.00 M176.05 M+-93.01 K+2.0%0.06%
JH

Janus Henderson Group Plc

Q1 2026

BUY1.70 M142.14 M+880.59 K+89.2%0.03%
JC

Jpmorgan Chase & Co

Q2 2026

SELL1.16 M102.10 M+-24.57 K+5.9%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY697.56 K63.00 M+350.43 K+117.2%0.01%
CC

Cadian Capital Management, LP

Q2 2026

SELL626.70 K56.60 M+-206.00 K-18.7%4.28%
MM

Millennium Management LLC

Q2 2026

SELL249.97 K22.58 M+-558.89 K-66.6%0.01%
CP

California Public Employees Retirement System

Q2 2026

BUY155.32 K14.03 M+1.75 K+9.3%0.01%
MG

Man Group Plc

Q2 2026

SELL67.56 K6.10 M+-355.72 K-82.8%0.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL16.78 K1.52 M+-368.00+5.8%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY9.84 K888.93 K+3.96 K+80.9%0.01%
FC

Farallon Capital Management LLC

Q1 2026

SELL2.80 K234.00 K+-2.20 K-48.9%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-835.07 K-100.0%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL0.000.00+-51.61 K-100.0%0.00%